Ascletis Pharma Inc. (HKG:1672)
Hong Kong · Delayed Price · Currency is HKD 13.00
-1.35 (-9.41%)
Nov 21, 2025, 11:59 AM HKT
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 14.23 billion as of November 20, 2025. Its market cap has increased by 934.98% in one year.
Market Cap
14.23B
Enterprise Value
12.27B
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.00
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 14.23B, a decrease of -9.27%. That is a compound annual growth rate of -1.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 14.23B | 390.21% |
| Dec 31, 2024 | 2.90B | 90.74% |
| Dec 29, 2023 | 1.52B | -70.46% |
| Dec 30, 2022 | 5.15B | 44.13% |
| Dec 31, 2021 | 3.58B | 13.38% |
| Dec 31, 2020 | 3.15B | -4.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 313.45B |
| Hansoh Pharmaceutical Group Company | 236.23B |
| JD Health International | 214.82B |
| Innovent Biologics | 154.92B |
| WuXi Biologics | 130.87B |
| Sino Biopharmaceutical | 124.78B |
| Akeso | 102.98B |
| Sichuan Kelun-Biotech Biopharmaceutical | 99.99B |